AUSTIN WILLIAMS: Open Payments
NPI 1265994222 · MARKSVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 18 payments from 10 companies in 2025. Trend: 2023 $485 · 2024 $290 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $94 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| ABBVIE INC. | 2 | $34 |
| Amgen Inc. | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $24 |
| Lilly USA, LLC | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: CAPLYTA, FARXIGA, VRAYLAR, OTEZLA, Auvelity, UZEDY, FREESTYLE LIBRE 3, AIRSUPRA.
Industry payments across LA — which companies pay providers there.
